Testing CMS-D002 for heavy bleeding from uterine fibroids
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests a capsule called CMS-D002 for heavy periods caused by uterine fibroids. It might help reduce your bleeding if you have fibroids at least 2 cm in size, regular cycles, and are between 18 and 50.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 50 years old and have not gone through menopause.
- Your body mass index (BMI) is at least 18.
- You have at least one fibroid 2 cm or larger seen on ultrasound.
- Your periods come every 21 to 35 days and last 14 days or less for the last three months.
- You are not pregnant, not breastfeeding, and have not given birth in the last 6 months.
- You agree to use birth control during the study and for 6 months after taking the drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if relugolix can reduce heavy menstrual bleeding caused by uterine fibroids. It may be an option for women who want to avoid surgery.
This trial tests an investigational medication called BT-114143 for people with heavy menstrual bleeding (abnormal uterine bleeding). The goal is to see if it is safe and effective in reducing blood loss during periods.
This early-stage study tests medicines that may help control heavy uterine bleeding by changing how blood clots work in the uterus. If you have regular periods and meet the setup rules, you may be asked to provide menstrual tracking and undergo an endometrial (uterine lining) biopsy.
This trial compares two medications (ergometrine and carbetocin) given during surgery to see which one is better at reducing bleeding while removing fibroids. Both drugs help the uterus contract to control blood loss.
This trial compares two treatments for painful or heavy menstrual bleeding caused by uterine fibroids: high-intensity focused ultrasound (HIFU) and myomectomy (surgery to remove fibroids). It may help you decide which option fits your needs.
This trial compares two surgical techniques to reduce bleeding during surgery to remove fibroids (benign tumors) from the uterus. The goal is to find the safest, least-bloody approach for women who need this procedure.
Hear when a new Uterine Fibroids With Menorrhagia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.